interleukin amplifies acute inflammation potential therapeutic target sepsis
sepsis frequently fatal condition characterized uncontrolled harmful host reaction microbial infection despite prevalence severity sepsis lack fundamental grasp pathophysiology report cytokine interleukin il- potentiates inflammation sepsis using mouse model abdominal sepsis showed innate response activator b cells produce il- induces myelopoiesis ly-6chigh monocytes neutrophils fuels cytokine storm il deficiency protects mice sepsis humans sepsis high plasma il levels associated high mortality even adjusting prognostic indicators study deepens understanding immune activation identifies il orchestrator emergency myelopoiesis reveals new therapeutic target treating sepsis
